Our Team

Jonathan Eneman, MD

Medical Director of Anna Jaques Cancer Center Affiliated with BIDMC

Dr. Eneman is board certified in internal medicine, hematology and oncology, and has served as the medical director of the cancer center since its inception. Dr. Eneman received his medical degree from the University of Vermont (UVM), served as an intern and resident at Beth Israel Deaconess Medical Center (BIDMC), and completed his fellowship in Hematology and Medical Oncology at UVM. After completing his fellowship, Dr. Eneman accepted a position with York Hospital in York, Maine where he proudly served as Chairman for the Department of Medicine and helped the oncology program receive the New Program Outstanding Achievement Award from the American College of Surgeons Commission on Cancer. He is inspired daily by both his coworkers and patients.

Claire Fung, MD

Radiation Oncologist, Alliance Radiation Oncology at Anna Jaques

Dr. Fung is a board-certified radiation oncologist trained at Harvard Medical School and then Massachusetts General Hospital, where she earned a prestigious fellowship award and served on staff for 14 years. Dr. Fung has served as vice president of Commonwealth Hematology Oncology in Quincy, MA. She previously served as medical director at South Suburban Oncology Center in Quincy. Along with producing several original reports, reviews and abstracts, she has taught radiation oncology to medical students at Harvard Medical School and Boston University School of Medicine.

Matthew Hall, MD

Radiology

Dr. Hall is a board-certified radiologist. He received his medical degree from the UMass School of Medicine and completed his radiology residency at Maine Medical Center. After completing his residency, Dr. Hall went on to perform a fellowship in body/oncology imaging at the Dana Farber Cancer Institute and Brigham and Women’s Hospital.

Peter Hartmann, MD, FACS

Medical Director of the Gerrish Breast Care Center at Anna Jaques

Dr. Peter Hartmann is a board-certified general surgeon who brings nearly 25 years of private surgical practice to the role of Medical Director. Since arriving in Newburyport, Dr. Hartmann has been involved with the American College of Surgeons’ Commission on Cancer since 1989. He has had a special interest in breast surgery for decades, and was among the first to use the sentinel node biopsy in New England in the 1990s. Over the years, he has performed approximately 1,000 breast procedures. As a dedicated breast surgeon he focuses exclusively on a variety of breast procedures related to the diagnosis and treatment of breast cancer.

Meghan Hession, NP

Family Nurse Practitioner/Oncology Nursing

Dr. Meghan Hession is a board-certified Family Nurse Practitioner, with additional certification in Oncology Nursing. Dr. Hession earned her advanced practice degree from University of Massachusetts at Amherst in 2018, after almost 15 years of nursing practice, most recently in the medical oncology setting. She was proud to present her Doctoral capstone work at both the Northern New England Clinical Oncology Society and Oncology Nursing Society Annual Meetings.  In addition to providing clinical support to our patients, Dr. Hession is the chairperson for our Survivorship Program and participates in quality improvement initiatives for the practice.

Michael Hitchcock, MD

Pathology

Dr. Michael Hitchcock joined Anna Jaques in September 2021 as Chief of Pathology and Medical Director of Laboratory Services. Dr. Hitchcock comes to AJH from the Waterbury Hospital in Waterbury, Connecticut, where he served as the medical director since 2017. He is board certified in Anatomic and Clinical Pathology as well as Hematopathology.

Kavitha Rao, MD

Pathology

Dr. Rao is a board-certified pathologist. She received her medical degree from Government Medical College in Mysore, India, and completed a residency and internship at University Hospitals of Cleveland in Cleveland, Ohio.

Donielle Sliwa, MD

Hematology/Oncology, Medical Oncology

Dr. Sliwa, MD, MPH is a graduate of St. George’s University School of Medicine, where she completed a combined medical degree and master’s degree in public health. After attending medical school, Dr. Sliwa completed her internal medicine residency training at Baystate Medical Center/Tufts University School of Medicine and her hematology and medical oncology fellowship at Baystate Medical Center/The University of Massachusetts Medical School.  Prior to attending medical school, she worked as a research study assistant on national and international clinical trials at the Memorial Sloan-Kettering Cancer Center.

Daphna Spiegel , MD

Radiation Oncologist, Alliance Radiation Oncology at Anna Jaques Hospital

Dr. Spiegel is a radiation oncologist at Beth Israel Deaconess Medical Center. She treats all types of cancer, but her clinical specialties include treatment of breast and gynecologic malignancies. Dr. Spiegel graduated from Tufts University School of Medicine and completed her radiation oncology residency training at Duke University, where she served as Chief Resident. She appreciates engaging in a multi-disciplinary team approach and partnering with patients to achieve high-quality and compassionate care. Dr. Spiegel’s research interests include understanding and minimizing toxicities related to cancer treatment. Her research has been published in journals such as Journal of Clinical Oncology and Cancer, and her work has been presented both at the national level and internationally. When not working, Dr. Spiegel enjoys spending time with her husband, two young children, and her adopted black Labrador retriever. 

Colleen Yavarow, DO

Hematology & Oncology

Dr. Colleen Yavarow is board certified in Medical Oncology and Internal Medicine and brings a wealth of experience in a hematology and oncology community practice setting. Dr. Yavarow received her medical education at the University of New England College of Osteopathic Medicine. She trained at Lahey Clinic and St. Elizabeth’s Medical  Center where she earned a prestigious fellowship award.

Nadine Tung, MD

Director, Cancer Genetics and Prevention Program, Cancer Center at BIDMC

Nadine Tung, MD is the director of the Cancer Genetics and Prevention Program at the Cancer Center at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School.

In addition to her clinical work in cancer genetics, Dr. Tung is a breast cancer medical oncologist with expertise in caring for women with breast cancer. She is also active in research in the areas of breast cancer and hereditary susceptibility genes which cause breast and ovarian cancer.

Dr. Tung attended Harvard Medical School and completed her internship, residence and fellowship at Beth Israel Deaconess Medical Center in Boston. She is board certified by the American Board of Internal Medicine in Medical Oncology.

Stuart Berman, MD

Director of Community Radiation Oncology, Cancer Center at BIDMC

Stuart M. Berman, MD, MBA is director of community radiation oncology services for the Cancer Center at Beth Israel Deaconess Medical Center. He is an instructor in radiation oncology at Harvard Medical School. He attended the University of Virginia School of Medicine and completed his residency at the Harvard Joint Center for Radiation Therapy in 1992. He is board certified in radiation oncology by the American Board of Radiology.

Marc Garnick, MD

Gorman Brothers Professor of Medicine at Harvard Medical School and Director of Community Cancer Services at BIDMC

Renowned for his role in leading-edge research, Marc B. Garnick MD serves as Director of Community Cancer Services for the Cancer Center at Beth Israel Deaconess Medical Center and is the Gorman Professor of Medicine at Harvard Medical School. Garnick received his bachelor degree from Bowdoin College and his medical degree from the University of Pennsylvania School of Medicine, where he also completed his internal medicine internship and residency. He also completed a research and clinical fellowship with the National Institutes of Health and a medical oncology fellowship at the Dana Farber Cancer Institute.

Garnick served as the principal investigator on the development of Lupron, a widely used hormonal therapy for prostate cancer and has also directed the clinical development of several other important cancer therapies. He currently serves on several advisory panels for the federal Food and Drug Administration, advising them on complicated issues related to the safety and efficacy of cancer treatments. He also serves as the editor in chief of the Harvard Medical School’s Annual Report on Prostate Diseases and its associated website, www.harvardprostateknowledge.org